119-HR-6178 Journalist Public Summary
119 · HR 6178 Increasing Access to Lung Cancer Screening Act
A bipartisan House bill would make annual lung‑cancer screening free for eligible Medicaid enrollees, ban prior authorization for those screenings across Medicaid, Medicare, and private insurance, and expand Medicaid coverage of quit‑smoking counseling and medications to all enrollees. It also funds outreach and orders a federal report on gaps in current screening guidelines. Status as of November 21, 2025: introduced and referred to House committees; not yet voted on.
Headline Summary
Make annual lung‑cancer screening easier to get: free for eligible people on Medicaid, no prior authorization across Medicaid/Medicare/private plans, and broader Medicaid coverage of quit‑smoking help.
What It Does
Plain‑English overview of H.R. 6178 (“Increasing Access to Lung Cancer Screening Act”).
The bill removes cost and paperwork barriers to recommended lung‑cancer screening and expands access to smoking‑cessation care. It ties eligibility to U.S. Preventive Services Task Force (USPSTF) guidelines, bars prior authorization for the annual screening, and requires Medicaid to cover counseling and medications to help people quit tobacco. It also funds federal outreach so high‑risk groups know they’re eligible.
- Medicaid: Requires coverage of an annual lung‑cancer screening for people for whom screening is recommended by USPSTF, with no patient cost‑sharing and no prior authorization; applies to Medicaid managed care plans. Effective for services on or after January 1, 2026.
- Medicaid tobacco cessation: Expands mandatory coverage of counseling and pharmacotherapy for quitting tobacco to all Medicaid enrollees (previously written for pregnant enrollees), without prior authorization and without cost‑sharing as a preventive service. Effective January 1, 2026.
- Medicare and Medicare Advantage: Prohibits prior authorization for the annual lung‑cancer screening when it is a covered Part B benefit. Effective January 1, 2026.
- Private insurance (group and individual): Bars prior authorization for the annual lung‑cancer screening when recommended by USPSTF, beginning with plan years on or after January 1, 2026.
- Education and outreach: Directs HHS to run a campaign, in consultation with patient and lung‑cancer advocacy groups, focused on high‑risk populations.
- Data and oversight: Requires a GAO report within one year of enactment on who is diagnosed versus who is currently eligible for screening, highlighting groups potentially missed by existing guidelines (examples named include firefighters, veterans, and women under 50).
Why It Matters
- Access and affordability: Ending copays in Medicaid and banning prior authorization aims to make a recommended, yearly screening easier to get—especially for lower‑income adults.
- Earlier detection: Simplifying access could shift more diagnoses to earlier, more treatable stages, which can improve outcomes and reduce intensive treatment later.
- Quit‑smoking support: Broader Medicaid coverage of counseling and medications addresses the main risk factor and may reduce future cancer cases.
- Administrative simplification: Uniform “no prior auth” rules across payers reduce red tape for patients and clinics, though insurers lose a utilization‑management tool.
Who’s For It
- Sponsors: Rep. Kathy Castor (D‑FL), Rep. Brian Fitzpatrick (R‑PA), and Rep. Debbie Wasserman Schultz (D‑FL).
- Likely supporters (based on the bill’s design and typical coalition patterns): patient and lung‑cancer advocacy groups, many clinicians and public‑health organizations, and Medicaid enrollee advocates who emphasize prevention and access.
- Their case in brief: screenings recommended by an expert body (USPSTF) should be easy to obtain; removing costs and prior authorization can boost uptake, catch cancers earlier, and reduce disparities.
Who’s Against It
- Potential opponents or skeptics: some private insurers and employer plan sponsors concerned about higher upfront costs and the loss of prior authorization as a utilization‑management tool; some state Medicaid programs wary of near‑term spending increases or administrative changes.
- Their case in brief: eliminating prior authorization can increase use (including some low‑value use) and costs; states may face budget pressures even if earlier detection yields long‑run savings.
What’s Next
Status as of November 21, 2025: H.R. 6178 was introduced on November 20, 2025 and referred to the House Energy & Commerce Committee and the Ways & Means Committee. Next steps typically include committee hearings and markups, a House floor vote, Senate consideration, and the President’s signature before any provisions take effect.
Key Dates and Dollars
Note: Funding is an authorization; Congress would still need to appropriate the dollars in annual spending bills for HHS to run the outreach campaign.
Discussion